Thrasyvoulos Tzellos
Stillingsbeskrivelse
Førsteamanuensis
Alexander J. Stratigos,
Marie A. Richard,
Clio Dessinioti,
Carle Paul,
Tamar Nijsten,
Paolo Gisondi
m.fl.:
The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population-based survey study
JEADV Clinical Practice 2024 DOI
Thrasyvoulos Tzellos,
Synne Ildahl Svendsen,
Mari Øvergaard,
Eldrid Oftestad,
Mari Lahelma,
Anna-Kaisa Asikainen
m.fl.:
Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare—A Survey-Based Patient Experience
Journal of Patient Experience (JPE) 2024 DOI
Anthony J. Dixon,
Athanassios Kyrgidis,
Howard K. Steinman,
John B. Dixon,
Michael Sladden,
Claus Garbe
m.fl.:
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients
Journal of the European Academy of Dermatology and Venereology 2024 DOI
Lindsey Greenlund,
Claire Herzog,
Zachary Wendland,
Katelyn Rypka,
John W. Frew,
Joslyn S. Kirby
m.fl.:
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Journal of the European Academy of Dermatology and Venereology 2024 DOI
Christos C. Zouboulis,
Athanassios Kyrgidis,
Afsaneh Alavi,
Gregor B. E. Jemec,
Antonio Martorell,
Angelo V. Marzano
m.fl.:
Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials
Journal of the European Academy of Dermatology and Venereology 2024 DOI
A. Dixon,
H.K. Steinman,
A. Kyrgidis,
H. Smith,
M. Sladden,
C. Zouboulis
m.fl.:
Online prediction tools for melanoma survival: A comparison
Journal of the European Academy of Dermatology and Venereology 2023 DOI
Kelsey R. Van Straalen,
Thrasyvoulos Tzellos,
Afsaneh Alavi,
Farida Benhadou,
Carlos Cuenca-Barrales,
Mathilde Daxhelet
m.fl.:
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort
Dermatology 2023 DOI
Piergiacomo Calzavara-Pinton,
Jarmila Čelakovská,
Hilde Lapeere,
Gregor Holzer,
Mona Al-Ahmad,
Chia-Yu Chu
m.fl.:
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study
Puneet Agarwal,
Snehal Balvant Lunge,
Nandini Sundar Shetty,
Priyanka Karagaiah,
Steven Daveluy,
Alex G. Ortega-Loayza
m.fl.:
Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review
Journal of Clinical Medicine 2022 DOI
Bria Midgette,
Andrew Strunk,
Oleg Akilov,
Afsaneh Alavi,
Christine Ardon,
Falk G. Bechara
m.fl.:
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project
Ratnakar Shukla,
Priyanka Karagaiah,
Anant Patil,
Katherine Farnbach,
Alex G. Ortega-Loayza,
Thrasyvoulos Tzellos
m.fl.:
Surgical Treatment in Hidradenitis Suppurativa
Journal of Clinical Medicine 2022 DOI
Thrasyvoulos Tzellos,
Kelsey R. van Straalen,
Athanassios Kyrgidis,
Afsaneh Alavi,
Noah Goldfarb,
Wayne Gulliver
m.fl.:
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa
Journal of the European Academy of Dermatology and Venereology 2022 DOI
Thrasyvoulos Tzellos,
Christos C. Zouboulis
:
Which hidradenitis suppurativa comorbidities should I take into account?
Experimental Dermatology 2022 DOI
Evangelos J. Giamarellos-Bourboulis,
Vincenzo Bettoli,
Gregor B.E. Jemec,
Veronique del Marmol,
Angelo V. Marzano,
Errol P. Prens
m.fl.:
Anti-COVID-19 measurements for hidradenitis suppurativa patients
Experimental Dermatology 2021 DOI
Christos C. Zouboulis,
John W. Frew,
Evangelos J. Giamarellos-Bourboulis,
Gregor B.E. Jemec,
Veronique del Marmol,
Angelo V. Marzano
m.fl.:
Target molecules for future hidradenitis suppurativa treatment
Experimental Dermatology 2021 DOI
Kelsey R. van Straalen,
Thrasyvoulos Tzellos,
Phillipe Guillem,
Farida Benhadou,
Carlos Cuenca-Barrales,
M. Daxhelet
m.fl.:
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study
Journal of American Academy of Dermatology 2021 DOI
Pavel V. Chernyshov,
Andrew Y. Finlay,
Lucia Tomas-Aragones,
Francoise Poot,
Francesca Sampogna,
Servando E Marron
m.fl.:
Quality of life in hidradenitis suppurativa: An update
International Journal of Environmental Research and Public Health (IJERPH) 2021 DOI
Christos C. Zouboulis,
Farida Benhadou,
Angel S. Byrd,
Nisha S. Chandran,
EJ Giamarellos-Bourboulis,
Gabriella Fabbrocini
m.fl.:
What causes hidradenitis suppurativa ? — 15 years after
Experimental Dermatology 2020 DOI
Christos C. Zouboulis,
Wayne Gulliver,
John Ingram,
Brian Kirby,
Evangelos J. Giamarellos-Bourboulis,
Maurizio Podda
m.fl.:
Endpoints of clinical trials for Hidradenitis Suppurativa: Proceedings of a round-table session
Experimental Dermatology 2020 DOI
Thrasyvoulos Tzellos,
Christos C. Zouboulis
:
Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
Jacob P. Thyssen,
Steffen Heegaard,
Lena Ivert,
Anita Remitz,
Tove Agner,
Marjolein de Bruin-Weller
m.fl.:
Management of ocular manifestations of atopic dermatitis: A consensus meeting using a modified delphi process
Acta Dermato-Venereologica 14. september 2020 DOI
Christos C. Zouboulis,
Falk Georges Bechara,
Janine L. Dickinson-Blok,
Wayne Peter Frances Gulliver,
Barbara H. Horváth,
Rosalind Hughes
m.fl.:
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization ? systematic review and recommendations from the HS ALLIANCE working group
Amit Garg,
Erica Neuren,
Denny Cha,
Joslyn S Kirby,
John R Ingram,
Gregor BE Jemec
m.fl.:
Evaluating Patients' Unmet Needs in Hidradenitis Suppurativa: results from the Global VOICE project
Journal of American Academy of Dermatology 2019 DOI
Linnea Thorlacius,
Amit Garg,
PT Riis,
SM Nielsen,
V Bettoli,
John R Ingram
m.fl.:
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa
British Journal of Dermatology 2019 DOI
Pavel V. Chernyshov,
Christos C. Zouboulis,
Lucia Tomas-Aragones,
Gregor Borut Ernst Jemec,
Åke Svensson,
Liana Manolache
m.fl.:
Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa
Journal of the European Academy of Dermatology and Venereology 2019 DOI
Øystein Grimstad,
Thrasyvoulos Tzellos,
Deirdre Nathalie Dufour,
Øyvind Magne Bremnes,
Inger Marie Skoie,
Ingrid Snekvik
m.fl.:
Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG)
Journal of the European Academy of Dermatology and Venereology 2019 DOI
Alexandra Boer Kimball,
Thrasyvoulos Tzellos,
Brian M Calimlim,
Henrique D Teixeira,
Ziqian Geng,
Martin M Okun
:
Achieving hidradenitis suppurativa response score is associated with significant improvement in clinical and patient-reported outcomes: Post hoc analysis of pooled data from PIONEER I and II
Pavel V. Chernyshov,
Christos C. Zouboulis,
Lucía Tómas-Aragonés,
Gregor Borut Ernst Jemec,
Liana Manolache,
Thrasyvoulos Tzellos
m.fl.:
Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa
Journal of the European Academy of Dermatology and Venereology 2018 DOI
Thrasyvoulos Tzellos,
H Yang,
F Mu,
B Calimlim,
J Signorovitch
:
Impact of hidradenitis suppurativa on work loss, indirect costs and income
CC Zouboulis,
Thrasyvoulos Tzellos,
A Kyrgidis,
GBE Jemec,
FG Bechara,
EJ Giamarellos-Bourboulis
m.fl.:
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity
British Journal of Dermatology 2017 DOI
Dominique C. van Rappard,
Jan R. Mekkes,
Thrasivoulos Tzellos
:
Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa
Dermatologic clinics 2016 DOI
Wayne Peter Frances Gulliver,
Christos C. Zouboulis,
Errol P. Prens,
Gregor Borut Ernst Jemec,
Thrasivoulos Tzellos
:
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
Reviews in endocrine and metabolic disorders (Print) 2016 DOI
Thrasyvoulos Tzellos
:
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma
Cochrane Database of Systematic Reviews 2015 DOI
Thrasyvoulos Tzellos
:
Interventions for melanoma in situ, including lentigo maligna
Cochrane Database of Systematic Reviews 2015 DOI
Thrasivoulos Tzellos,
Christos C. Zouboulis,
Wayne Peter Frances Gulliver,
Amon D. Cohen,
Pierr Wolkenstein,
Gregor Borut Ernst Jemec
:
Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta-analysis of observational studies
British Journal of Dermatology 2015 DOI
Christos C. Zouboulis,
Veronique Del Marmol,
Ulrich Mrowietz,
Errol P. Prens,
Thrasivoulos Tzellos,
Gregor B.E. Jemec
:
Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation
Dermatology 2015 DOI
C.C. Zouboulis,
E.J. Giamarellos-Bourboulis,
G.B.E. Jemec,
A.C. Katoulis,
E.P. Prens,
Thrasyvoulos Tzellos
:
Significant spontaneous daily fluctuation of inflammatory nodules and abscesses but not of draining tunnels in hidradenitis suppurativa/acne inversa
Journal of the European Academy of Dermatology and Venereology 2024 DOI
Hessel H. Van Der Zee,
Johanna C. Van Huijstee,
Kelsey R. Van Straalen,
Gregor B.E. Jemec,
Christos C. Zouboulis,
Thrasyvoulos Tzellos
m.fl.:
Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4
Dermatology 2024 DOI
Athanassios Kyrgidis,
Anthony J. Dixon,
Michael Sladden,
Howard K. Steinman,
Christos C. Zouboulis,
Aimilios Lallas
m.fl.:
Sentinel lymph node biopsy may no longer be a critical component of melanoma management
Journal of the European Academy of Dermatology and Venereology 2024 DOI
A.J. Dixon,
H.K. Steinman,
A. Kyrgidis,
H. Smith,
M. Sladden,
C. Zouboulis
m.fl.:
Improved methodology in determining melanoma mortality and selecting patients for immunotherapy
Journal of the European Academy of Dermatology and Venereology 2023 DOI
V.A. Zouboulis,
A.F. Massa,
G. Nikolakis,
E.P. Prens,
J.C. Szepietowski,
Thrasyvoulos Tzellos
m.fl.:
Baseline knowledge of dermatology specialists/residents on hidradenitis suppurativa and immediate learning outcome after their participation at an EADV School
Journal of the European Academy of Dermatology and Venereology 2023 DOI
Christos C. Zouboulis,
Errol P. Prens,
Christopher J. Sayed,
Alejandro Molina-Leyva,
Vincenzo Bettoli,
Marco Romanelli
m.fl.:
International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
Journal of the European Academy of Dermatology and Venereology 2023 DOI
C.C. Zouboulis,
B. Hrvatin Stancic,
A. Abaitancei,
M.J. Guimarães,
I.L. Lobo,
A.F. Massa
m.fl.:
The inter-rater reliability of IHS4 corroborates its aptitude as primary outcome measurement instrument for large clinical studies in hidradenitis suppurativa
Journal of the European Academy of Dermatology and Venereology 2023 DOI
Heidi A. Kurn,
McKenna Abercrombie,
Thrasyvoulos Tzellos,
Robert P. Dellavalle
:
From the Cochrane library: Interventions for melanoma in situ, including lentigo maligna
Journal of American Academy of Dermatology 2022 DOI
Mathilde Daxhelet,
Mathieu Daoud,
Mariano Suppa,
Farida Benhadou,
Hassane Njimi,
Thrasyvoulos Tzellos
m.fl.:
European registry for hidradenitis suppurativa: state of play
Journal of the European Academy of Dermatology and Venereology 2021 DOI
Thrasyvoulos Tzellos,
Christos C. Zouboulis
:
Correction to: Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice (Dermatology and Therapy, (2020), 10, 1, (63-71), 10.1007/s13555-020-00354-2)
Dermatology and Therapy 2020 DOI
M. Daxhelet,
Mariano Suppa,
Farida Benhadou,
Vahid Djamei,
Thrasyvoulos Tzellos,
Gisli Ingvarsson
m.fl.:
Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software
Journal of the European Academy of Dermatology and Venereology 2016 DOI
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →